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SUMMARY Reports on clinical and histologic follicular alterations in 
patients previously diagnosed with mycosis fungoides (MF) or at the time of 
MF diagnosis are rare. The clinical and histologic criteria to distinguish MF 
associated with follicular mucinosis from follicular MF are a matter of debate. 
A patient is described with advanced clinical and histologic alterations 
predominated by follicular lesions and presence of mucin. In the early stage 
of the disease, folliculotropism was clinically and histologically present but 
less pronounced than epidermotropism and classic plaque-like lesions. 
The patient died four years after the diagnosis. As the term ‘folliculotropic’ 
describes a particular histopathologic finding, we consider it correct to use 
the term “folliculotropic MF” to denote atypical lymphocyte folliculotropism 
in the absence or presence of mild epidermotropism, presence of mucin, or 
no evidence for intrafollicular mucin. Folliculotropic MF seems to represent 
a specific clinicopathologic entity which may have a poorer prognosis than 
classic MF. 
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INTRODUCTION
 Follicular mucinosis can occur as a benign pri-
mary ‘idiopathic’ disorder or as a secondary sequel 
of various benign or malignant diseases. It mostly 
occurs in association with cutaneous T-cell lym-
phoma mycosis fungoides (MF). MF can precede, 
concur or develop decades after the occurrence of 
follicular mucinosis. In recent years, the term fol-
licular MF (also folliculocentric or pilotropic MF) 
has been introduced to denote the rare clinical MF 
variants characterized by follicular papules, follicu-
lar keratosis, comedo-like lesions, and epidermal 
cysts. Histologically, perifollicular infiltrations with 
pronounced folliculotropism are found, generally 
without epidermotropism or follicular mucinosis (1).
 We present a patient in whom the classic form 
of MF was diagnosed at age 67, whereas clinically 
and histopathologically overt follicular localization 
of the lesions with follicular mucinosis developed 
two years later. The patient died four years after 
the diagnosis.
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CASE REPORT
 In a 67-year-old patient, the classic form of MF, 
stage I A (T1N0B0M0) was diagnosed on his first 
hospitalization at our Department in July 2000. 
Until the onset of cutaneous symptoms, the pa-
tient was mostly healthy, apart from allergic rhini-
tis and conjunctivitis in spring he had been suffer-
ing from his young age. The clinical picture was 
predominated by sparsely disseminated, poorly 
infiltrated and unsharply delineated erythematous 
plaques (Fig. 1a). Histology of the skin biopsy 
revealed dense infiltration with atypical lympho-
cytes, along with epidermotropism and Pautrier’s 
microabscesses (Fig. 1b). Besides epidermotro-
pism, the nuchal region skin biopsy (Fig. 2a) also 
showed folliculotropism without mucin formation 
(Fig. 2b). Upon examinations and staging of the 
disease, two-month therapy with peroral photo-
sensitizer and UVA (PUVA) in combination with 
local corticosteroid was initiated, which resulted 
in almost complete disappearance of the lesions. 
In June 2002, the patient was rehospitalized for 
intense pruritus, subtotal alopecia and dissemi-
nated follicular skin-colored papules with follicular 
keratosis and mucinorrhea. The follicular papules 
were densely grouped in the nuchal and lateral 
trunk regions (Fig. 3a and 3b). Physical exami-
nation revealed bilateral lymphadenopathy of the 
inguinal region and palpable liver by 2-3 cm in 
MCL. Routine biochemistry testing indicated mild 
leukocytosis (10.4-11.3), eosinophilia in differen-
tial blood count (23%-32%), lymphopenia (11%-
17%) and an increased level of lactate dehydro-
genase (LDH 615; normal <460), whereas other 
findings were within the normal limits. Histology of 
the nuchal skin biopsy showed large follicles with 
keratin, dense and mostly perifollicular infiltrates 
composed of atypical lymphocytes with folliculot-
ropism (Fig. 4a) and numerous eosinophils in the 
infiltrate. Intrafollicularly, there were large areas of 
mucinous degeneration (Fig. 4b) that were alcian 
blue positive (Fig. 4c) and PAS negative. Immu-
Figure 1a. Erythematous, sparsely infiltrated 
plaques on lower limbs, at the time of the “plaque 
stage” mycosis fungoides diagnosis.
Figure 2a. Confluent follicular papules forming an 
occipital plaque, at the time of diagnosis.
Figure 1b. Dense, almost thread-like infiltrate of 
atypical lymphocytes in the dermis, with Pautrier’s 
microabscesses, at the time of diagnosis (H&E 
staining, original magnification x40). 
Figure 2b. Pautrier’s microabscesses in the in-
fundibular segment of hair epithelium, with dense 
perifollicular infiltration, at the time of diagnosis 
(H&E staining, original magnification x40). 
Radoš et al.     Acta Dermatovenerol Croat
Folliculotropic mycosis fungoides – case report                  2006;14(2):94-99 
ACTA DERMATOVENEROLOGICA CROATICA
96
nohistochemistry pointed to the CD3+CD4+CD8- 
lymphocyte phenotype (Fig. 4d and 4e). 
 X-ray, ultrasonography and computed tomog-
raphy of the chest, abdomen and pelvis showed 
no lymph node enlargement. Biopsy specimen 
of a clinically enlarged lymph node in the right in-
guinal region showed occasional lymphatic cells 
with polymorphic nuclei, thus extirpation and his-
topathologic examination of the lymph node were 
performed to reveal only architectural lymph node 
impairment in terms of paracortex expansion with 
no mycosis cells. There were no Sézary cells in 
peripheral blood smears. Bone marrow biopsy 
showed a more intense cellularity with regular re-
lations and appearance of all three cell lines. The 
disease staging was IIA (T2N1B0M0) and therapy 
included retinoid (acitretin) with PUVA (RePUVA) 
with minimal effect. Remission of pruritus and flat-
tening of the papules with partial hair growth oc-
Figure 3a. Pronounced follicular localization of 
papules with clinically overt mucinorrhea on lateral 
aspects of the neck, two years of the diagnosis. 
Figure 3b. Follicular pin-size papules, densely 
and uniformly distributed on lateral aspects of the 
trunk, two years of the diagnosis.
Figure 4b. Mucinous degeneration of hair epithe-
lium, two years of the diagnosis (H&E staining, 
original magnification x80).
Figure 4a. Dense, deep, predominantly peri- and 
infrafollicularly localized infiltrates of atypical lym-
phocytes without epidermotropism, two years of 
the diagnosis (H&E staining, original magnifica-
tion x40). 
curred upon the introduction of peroral corticoste-
roids at a dose of 32 mg with dosage tapering, and 
methotrexate 2.5 mg daily, prescribed in consulta-
tion with a hematologist. As reported by his family 
members, the patient was treated for pneumonia 
at Department of Medicine – Hematology at the 
end of 2003. The patient died in mid-2004.
DISCUSSION
 MF has a plethora of clinicopathologic mani-
festations. Many variants of this lymphoma differ 
substantially from the classic Alibert-Bazin dis-
ease and are therefore sometimes referred to as 
“atypical” forms of the disease (2) or may mimick 
other dermatoses (3). In spite of this heterogeneity, 
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the clinical variants such as bullous MF, hypo- or 
hyperpigmented MF have the clinical course in 
common with classic MF, thus they are not con-
sidered specific MF variants. Unlike these forms, 
MF associated with follicular mucinosis and paget-
oid reticulosis have specific clinicopathologic fea-
tures with the course and prognosis different from 
classic MF, thus being categorized as specific MF 
variants according to the European Organization 
for Research and Treatment of Cancer (EORTC) 
classification (4). 
 Traditional descriptions of MF associated with 
follicular mucinosis are characterized by the pres-
ence of folliculotropic infiltrate and mucous degen-
eration of hair follicles (follicular mucinosis) with 
epidermotropism and Pautrier’s microabscesses. 
Such cases of follicular mucinosis associated 
with MF should be distinguished from so-called 
idiopathic follicular mucinosis; however, there are 
different opinions about the issue (5-7). Additional 
studies are necessary to elucidate the relationship 
between MF associated follicular mucinosis and 
idiopathic follicular mucinosis. The relationship 
between follicular mucinosis and MF has not yet 
been fully clarified either. Cases of MF diagno-
sis with clinical and histologic (predominantly or 
exclusively) follicular involvement but without fol-
licular mucinosis have been described as follicu-
locentric, pilotropic and follicular MF (8-19). The 
absence of mucin and complete lack of epidermal 
involvement with neoplastic infiltration were the 
specific criteria upon which some authors based 
the diagnosis of follicular MF (8-14,17,19), where-
as others did not insist on these criteria, admitting 
the diagnosis of follicular MF also in the presence 
of mucin (15,16,18) and/or epidermotropism (8), 
and concurrent presence of classic MF lesions 
(9,10). Until the study performed by van Doorn 
et al. (20), these were mostly isolated reports or 
studies in small patient samples. Some authors 
used to emphasize the malignant and progressive 
course of follicular MF with rapid progression to 
lymph nodes (16) or transformation to high ma-
lignancy lymphoma (13). Recent studies have 
shown that there are no differences in the clinical 
picture and clinical course between folliculotropic 
MF with and without associated follicular mucino-
sis (21). In order to avoid terminological confusion, 
the new World Health Organization – European 
Organization for Research and Treatment of Can-
cer (WHO-EORTC) classification prefers the term 
folliculotropic MF for all MF variants characterized 
Figures 4d and 4e. Immunohistochemistry: the 
majority of atypical lymphocytes were CD4+ and 
CD8- (APAAP).
Figure 4c. Blue stained material represents posi-
tive reacting mucin (alcian blue staining, original 
magnification x80). 
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by the presence of folliculotropic infiltrate irrespec-
tive of mucin. Biologically, the presence of deep 
follicular and perifollicular infiltrates of neoplastic 
lymphocytes is of utmost importance, lowering the 
efficacy of traditional skin therapy such as PUVA 
and RePUVA. In contrast to classic MF, the clini-
cal picture of folliculotropic MF is predominated 
by follicular localization of lesions, e.g., grouped 
follicular papules, follicular keratosis, epidermal 
cysts, acneiform lesions, indurated plaques, and 
occasionally tumors mostly involving the head 
and neck. Cutaneous lesions are associated with 
alopecia and occasionally with mucinorrhea. Un-
like classic MF, pruritus is severe and may fre-
quently serve as a good parameter to assess the 
disease progression. Histopathology reveals pri-
marily perivascular and periadnexal localization 
with variable infiltration of follicular epithelium with 
small, medium and large hyperchromatic lympho-
cytes with cerebriform nuclei and sparing epider-
mis (folliculotropism instead of epidermotropism). 
Follicular mucinosis is found in most cases, which 
is demonstrated by alcian blue stain. In 70%-80% 
of patients with folliculotropic MF, the prognosis 
(disease specific 5-year survival) is comparable 
to the prognosis of classic tumor stage MF but is 
much worse in patients with classic “plaque stage” 
disease. The Netherlands Group for Lymphomas 
classifies patients with follicular MF as tumor stage 
disease irrespective of the clinical appearance of 
the lesions (20).
 Due to therapeutic resistance, total skin elec-
tron beam irradiation (TSEB) is recommended as 
therapy of choice for follicular MF (20,21).  
 We are inclined to believe that it was a case of 
classic MF conversion to the folliculotropic form of 
MF with follicular mucinosis rather than follicular 
MF, which has defined clinical and histologic crite-
ria. As reported by van Doorn et al., in follicular MF 
the lesions mostly involve the head and neck, but 
there are no (or very few) more or less infiltrated 
plaques on the trunk and thighs or atypical T-lym-
hocyte epidermotropism. 
 Although the exact cause of death remained 
unknown and could only be speculated (e.g., ex-
tracutaneous dissemination of the disease, trans-
formation to lymphoma of high grade of malignan-
cy, complications of immunosuppressive therapy), 
the fact is that the patient died four years after the 
diagnosis, suggesting a highly aggressive and 
progressive course of the disease with therapeutic 
complications, which is consistent with the known 
data on worse survival prognosis in patients with 
folliculotropic MF. We also consider that follicular 
MF (as defined according to van Doorn’s criteria) 
and “MF associated follicular mucinosis” belong to 
the spectrum of MF with hair follicle as a predilec-
tion site, thus this type of MF should preferably 
be termed folliculotropic MF for practical reasons, 
primarily for patient follow up, proper choice of 
therapy, and prognosis.
References
1. Sangűeza OP, Lu D. Mycosis fungoides. New 
insights into an old problem. Arch Dermatol 
2002;138:244-6.
2. Kazakov DV, Burg G, Kempf W. Clinicopatho-
logical spectrum of mycosis fungoides. J Am 
Acad Dermatol 2004; 18:397-415.
3. Zackheim HS, McCalmont TH. Mycosis fun-
goides: the great imitator. J Am Acad Dermatol 
2002;47:914-8.
4. Willemze R, Kerl H, Sterry W, Berti E, Cerroni 
L, Chimenti S, et al. EORTC classification for 
primary cutaneous lymphomas: a proposal 
from the Cutaneous Lymphoma Study Group 
of the European Organization for Research 
and Treatment of Cancer. Blood 1997;90:354-
71.
5. Cerroni L, Fink-Puches R, Back B, Kerl H. Fol-
licular mucinosis. A critical reappraisal of clini-
copathologic features and association with 
mycosis fungoides and Sézary syndrome. 
Arch Dermatol 2002;138:182-9.
6. Bőer A, Guo Y, Ackerman AB. Alopecia muci-
nosa is mycosis fungoides. Am J Dermatopa-
thol 2004;26:33-52.
7. LeBoit PE. Alopecia mucinosa, inflamma-
tory disease or mycosis fungoides: must we 
choose? And are there other choices? Am J 
Dermatopathol 2004;26:167-70.
8. Lacour JP, Castanet J, Perrin C, Ortonne JP. 
Follicular mycosis fungoides. A clinical and 
histologic variant of cutaneous T-cell lympho-
ma: report of two cases. J Am Acad Dermatol 
1993;29:330-4.
9. Aloi F, Tomasini C, Pippione M. Mycosis fun-
goides and eruptive epidermoid cysts: a unique 
response of follicular and eccrine structures. 
Dermatology 1993;187:273-7.
10. Goldenhersh MA, Zlotogorski A, Rosenmann 
E. Follicular mycosis fungoides. Am J Derma-
topathol 1994;16:52-5.
Radoš et al.     Acta Dermatovenerol Croat
Folliculotropic mycosis fungoides – case report                  2006;14(2):94-99 
ACTA DERMATOVENEROLOGICA CROATICA
99
11. Pereyo NG, Requena L, Galloway J, Sangűeza 
OP. Follicular mycosis fungoides: a clinico-
histopathological study. J Am Acad Dermatol 
1997;36:563-8.
12. Grau C, Pont V, Matarredona J, Fortea JM, Ali-
aga A. Follicular mycosis fungoides: presenta-
tion of a case and review of the literature. J 
Eur Acad Dermatol Venerol 1999;13:131-6.
13. Klemke CD, Dippel E, Assaf C, Hummel M, 
Stein H, Goerdt S, et al. Follicular mycosis 
fungoides. Br J Dermatol 1999;141:137-40.
14. Fraser-Andrews E, Ashton R, Russel-Jones 
R. Pilotropic mycosis fungoides presenting 
with multiple cysts, comedones and alopecia. 
Br J Dermatol 1999;140:140-4. 
15. Campanati A, Giangiacomi M, Goteri G, Pen-
na L, Turtù S, Offidani AM. A case of follicular 
mycosis fungoides with follicular mucinosis: a 
rare association. Am J Dermatopathol 2002; 
24:423-6.
16. Bonta MD, Tannous ZS, Demierre MF, Gon-
zalez E, Harris NL, Duncan LM. Rapidly 
progressing mycosis fungoides presenting 
as follicular mucinosis. J Am Acad Dermatol 
2000;43:635-40.
17. Zipprich F, Bräuninger W, Knop J, Enk A. Fol-
likulare Mycosis fungoides (FMF) – Ein selte-
nes Krankheitsbild. Hautartzt 2001;3:240-3.
18. Özdemir M, Demirkesen C, Arzuhal N, Tűzűn 
Y. Mucin-poor follicular mycosis fungoides. Int 
J Dermatol 2002;41:112-4.
19. Monopoli A, Annessi G, Lombardo GA, Baliva 
G, Girolomoni G. Purely follicular mycosis fun-
goides without mucinosis: report of two cases 
with review of the literature. J Am Acad Der-
matol 2003;48:448-52.
20. Doorn van R, Scheeffer E, Willemze R. Fol-
licular mycosis fungoides, a distinct disease 
entity with or without associated follicular mu-
cinosis. Arch Dermatol 2002;138:191-8.
21. Willemze R, Jaffe S, Burg G, Cerroni L, Ber-
ti E, Swedlow SH, et al. WHO-EORTC clas-
sification for cutaneous lymphoma. Blood 
2005;105:3768-85.
Radoš et al.     Acta Dermatovenerol Croat
Folliculotropic mycosis fungoides – case report                  2006;14(2):94-99 
Nivea cream for your children, year 1934.
(from the collection of Mr. Zlatko Puntijar)
ACTA DERMATOVENEROLOGICA CROATICA
